Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $6.5 billion.

  • Bristol Myers Squibb's Other Non-Current Assets rose 604.42% to $6.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.5 billion, marking a year-over-year increase of 604.42%. This contributed to the annual value of $6.5 billion for FY2025, which is 604.42% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Other Non-Current Assets stood at $6.5 billion, which was up 604.42% from $6.3 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Other Non-Current Assets ranged from a high of $7.4 billion in Q3 2021 and a low of $4.7 billion during Q2 2022
  • Moreover, its 5-year median value for Other Non-Current Assets was $5.9 billion (2025), whereas its average is $5.8 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Other Non-Current Assets tumbled by 3590.44% in 2022 and then soared by 2374.69% in 2024.
  • Bristol Myers Squibb's Other Non-Current Assets (Quarter) stood at $5.5 billion in 2021, then fell by 10.75% to $4.9 billion in 2022, then rose by 8.7% to $5.4 billion in 2023, then increased by 13.69% to $6.1 billion in 2024, then grew by 6.04% to $6.5 billion in 2025.
  • Its Other Non-Current Assets was $6.5 billion in Q4 2025, compared to $6.3 billion in Q3 2025 and $5.9 billion in Q2 2025.